abstract |
The invention provides tetrahydronaphthyridine and related compounds, pharmaceutical compositions, methods of inhibiting RORĪ³ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydronaphthyridine and related compounds. |